key: cord-0972205-hgajjelb authors: Ray, Manisha; Sable, Mukund Namdev; Sarkar, Saurav; Hallur, Vinay Kumar title: Essential interpretations of bioinformatics in COVID-19 pandemic date: 2020-12-17 journal: Meta Gene DOI: 10.1016/j.mgene.2020.100844 sha: b71d86ca3cfffd311556dcd30222c712029be327 doc_id: 972205 cord_uid: hgajjelb The currently emerging pathogen SARS-CoV-2 has produced the global pandemic crisis by causing COVID-19. The unique and novel genetic makeup of SARS-CoV-2 has been created puzzle in biological research, due to which the potential drug/vaccine candidates have not yet been discovered by the scientific community. Meanwhile, the advantages of bioinformatics in viral research had created a milestone since last few decades. The exploitation of bioinformatics tools and techniques has successfully interpreted this viral genomics architecture. Some major in silico studies involving next-generation sequencing, genome-wide association studies, computer-aided drug design etc. have been effectively applied in COVID-19 research methodologies and discovered novel information on SARS-CoV-2 in several ways. Nowadays the implementation of in silico studies in COVID-19 research has not only sequenced the SARS-CoV-2 genome but also properly analyzed the sequencing errors, evolutionary relationship, genetic variations, putative drug candidates against SARS-CoV-2 viral genes etc. within a very short time period. These would be very needful towards further research on COVID-19 pandemic and essential for vaccine development against SARS-CoV-2 which will save public health. ). There are certain software and databases have reportedly used for interpretation of metagenomics applications (Table 2) . Obtaining virus genome sequence directly from clinical samples is still a challenging (Table 4 ). In addition to the SNP analysis, the incorporation of haplotype diversity analysis with phylogenetic analysis has been frequently used in the SARS-CoV-2 research analyses to study the evolution and population demography of SARS-CoV-2 globally (Ramirez et al., Toms et al., 2020). This generated novel information on SARS-CoV-2 infectious genes are helping the researchers in the vaccine development against SARS-CoV-2, according to the identified viral genes coding regions, genetic sequence variations and molecular differentiations between the isolated species throughout the world. All the reported genomic experiments and analyses including SNP study, phylogenetic analysis, primer designing etc J o u r n a l P r e -p r o o f have been carried out through high throughput bioinformatics tools and techniques which provide an appropriate pipeline for data analyses and annotations (Table 5) . Drug design is very challenging, expensive, time consuming and an integrated rising discipline (Bisht and Singh, 2019) . In the interim, the field of bioinformatics has become a crucial part of the drug design that plays a vital role for the validation of drug targets. It can help in the understanding of complex biological processes to improve drug discovery (Choudhury and Saikia, 2018) . The in silico screening or computer-aided drug design (CADD) has signified as a dominant practice because of its proper algorithms including the development of digital repositories for the study of chemical interaction relationships, computer programs for designing compounds with unusual physicochemical characteristics as well as tools for systematic assessment of potential lead candidates etc. in drug discovery and development (Song et al., 2009) . Also, the additional benefits like cost-saving, time to market, in-sight knowledge of drug-receptor interaction, speed up in drug discovery and development increases its popularity in scientific researches (Ramirez et al., 2020). (Table 6 ). This immediate and effective action has not only predicted novel putative natural inhibitors but also re- (Table 6 ). For the successful completion of CADD, various bioinformatics tools and databases have been used since last decades and would be used in further research ( Table 7 ). The overall in silico processes are established in an order to perform a task in a sequential manner. From the beginning metagenomics to the end CADD have interconnected and represented the applications of bioinformatics in a single flow diagram (Fig. 1) . Wide application of robust algorithm based tools and information perceived from several public repository have enriched the knowledge spheres of modern life science research. The available bioinformatics tools and techniques are simple, accurate, cost effective, economical and freely available on internet, enabling their universal use for different research purposes. The above mentioned online repositories including PDB, PubChem, DrugBank, NCBI gene/genome databases, UCSC genome database, Uniprot, dbSNP, GEO, SRA, ENA (Table 2 ), (Table 5) , (Table 7) etc have updated frequently with huge novel datasets, which provides much authenticated and useful information to the users to carry out their research purposes. However, there is some limitations in use of certain tools particularly used for drug design such as Modeller (Table 7) or any other software generated 3D structure of proteins is approximate, which needs to be properly validated through crystallographic method for further study. The analysed docking parameters based on predefined algorithms of autodock (Table 7) should be simulate further to analyse the proper stability between target and drug candidate interactions. Likewise, some softwares including Schrodinger, Discovery studio (Table 7) , PAUP (Table 5 ) etc are creating limitations for researchers during data analysis and accession, as they are customized or paid software. Apart from the above major drawbacks/limitations some minor flaws are associated with the using of tools and software i.e. error during software installation, software dependencies particularity the type of operating systems, high speed internet network connection, high core computer facility etc. The designed tools and software are meant for respective analyses, the user cannot modify the algorithms and outputs according to own interest, the user need to use different respective software for different purposes to get the authenticate results. The knowledge about different programming languages like Perl, R, Python and Linux operating system is necessary to work with different bioinformatics software as well as to rewrite coded needed to solve particular J o u r n a l P r e -p r o o f biological problem computationally, in particular for software used for next generation sequencing analyses. The observations on SARS-CoV-2 will be explored extensively through bioinformatics and its applications variously. The researchers can also elucidate the SNPs in host body after affected with COVID-19. According to the modified nucleotides/genes novel primers can be designed for polymerase chain reaction through computational primer design algorithms. Apart from the drug design, putative inhibitory peptide can be created against SARS-CoV-2 viral genes. These further ideas would exploit many more denovo information of SARS-CoV-2, which will help the clinicians to add novel medication insights in the diagnosis procedures. The outburst of COVID-19 throughout the world is a big challenge for people to overcome this. Advances in bioinformatics techniques has been proved as the most advanced and effective technique in biomedical research. The high throughput screening and accuracy of data analysis have made this possible. The vast utilization of computational approaches in the current pandemic situation has effectively used from the preliminary stage of viral sample identification to the end stage of drug design by discovering novel information on SARS-CoV-2 genomic contents, variations, diversity within the species and predicted potential drug/ vaccine candidates against the viral genes within a very short period. In the present economically down condition, the successfully implementation of bioinformatics approaches against SARS-CoV-2 is a great achievement for scientific community. No funding has been received for this work. Design new target-specific primers in one step as well as to check the specificity of pre-existing primers and also placing primers based on exon/intron locations and excluding single nucleotide polymorphism (SNP) sites in primers. SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins An Extensive Meta-Metagenomic Search Identifies SARS-CoV-2-Homologous Sequences in Pangolin Lung Viromes In silico Identification of potential Drug Target and Analysis of Effective Single Nucleotide Polymorphisms for autism spectrum Disorder MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences Phylogeny.fr: robust phylogenetic analysis for the non-specialist Inferring evolutionary trees with PAUP* DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets popart: full-feature software for haplotype network construction Primer3--new capabilities and interfaces Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction Role of computer aided drug design in drug development and drug discovery Essential Basic Protocol in Computer Aided Drug Designing: Efficiency and Challenges Recent advances in computer-aided drug design In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2 A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19 silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19 Structure-based drug designing and immunoinformatics approach for SARS-CoV-2 In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) Druggability for COVID19 -in Silico Discovery of Potential Drug Compounds Against Nucleocapsid (N) Protein of SARS-CoV-2 Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches The authors declare that they have no conflict of interest. Molecular visualization program for displaying, animating, and analyzing large biomolecular systems using 3-D graphics and built-in scripting.